Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
05/2003
05/21/2003EP1312637A2 Ultraviolet radiation absorbents for thermoplastic polymers and methods of producing same
05/21/2003EP1311497A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv)
05/21/2003EP1311496A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iii)
05/21/2003EP0971709B1 Novel compounds useful as neuro-protective agents
05/21/2003EP0964863B1 Oxazolidines as 5-ht2a-antagonists
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1109026C Sidechain-beering taxanes like compounds
05/21/2003CN1109024C Fluoric derivative of N-phenyl-3-oxazolylamine (thiazolylamine) and its preparing process and application
05/20/2003US6566566 Dimerization of a C6-12 olefin mixture in which the hexene isomer fraction has less than 30% by weight of linear isomers in the presence of a nickel catalyst; derivatization to give primary alcohols, and optional subsequent alkoxylation
05/20/2003US6566553 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566495 Biosynthesis of preferential biopolymers; provide substrate, electrically activate preferential positions, bind monomer, repeat, recover biopolymers
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003CA2137694C Acaricide
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2003039746A1 Catalysts
05/15/2003US20030092916 Process for the preparation of thiazolidinedione derivatives
05/15/2003US20030092747 Secretase inhibitor
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/14/2003EP1310495A2 Glycidyl amines and their use in the preparation of HIV protease inhibitors
05/14/2003EP1310494A1 PPAR (delta) ACTIVATORS
05/14/2003EP1309577A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/14/2003EP0970077B1 Improved method for producing thiazolidinediones, and new thiazolidinediones
05/14/2003CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/13/2003US6563003 Process to produce amino alcohol salts
05/13/2003US6562980 Method for producing 5-aryloxymethyl-2-oxazolidinones
05/13/2003US6562967 Drug screening; purity
05/13/2003US6562966 Combining a racemic or a diastereomeric mixture of a chiral substrate with a nucleophile, in the presence of a chiral non-racemic catalyst
05/13/2003US6562944 Generation of preferential halogen compound; obtain carboxylic acid mixture, incubabte with halogenated compound, recover by-product
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562844 Oxazolidinone combinatorial libraries, compositions and methods of preparation
05/13/2003US6562817 Suppressants of the IgE production
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/13/2003CA2126461C Novel acid anhydrides and preparation and use thereof
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037085A1 Optically active herbicidal (r)-phenoxypropionic acid-n-methyl-n-2-fluorophenyl amides
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087935 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/08/2003US20030087928 Novel anilide compounds and drugs containing the same
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087151 Low melting point
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308084A1 Synergistic UV absorber combination
05/07/2003EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
05/07/2003EP1307182A2 Pharmaceutical composition for transdermal delivery of befloxatone
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP0912510B1 Nickel catalyzed addition of -nh- containing compounds to vinyl and aryl halides
05/07/2003EP0858464B1 Thrombin inhibitors
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/06/2003US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
05/06/2003US6559305 Linezolid—crystal form II
05/06/2003US6559100 2-benzoyl-cyclohexane-1,3-diones
05/02/2003EP1305292A1 Biphenyl carboxamides
05/02/2003EP1305270A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
05/01/2003WO2003035610A1 Sulfonamide derivative having mmp inhibitory activity
05/01/2003WO2003035609A1 Zwitterionic imides
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2002081478A3 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
05/01/2003US20030083353 Beta-secretase inhibitors
05/01/2003US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030082831 Apparatus for use in the synthesis of preferential biopolymers
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003CA2463290A1 Zwitterionic imides
04/2003
04/30/2003CN1107059C Azole derivative
04/24/2003WO2003033467A1 Nitroso diphenylamine derivatives as nitrogen monoxide generating agents
04/24/2003WO2003032908A2 Novel prodrugs of n-h bond-containing compounds and methods of making thereof
04/24/2003WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase
04/24/2003US20030078424 Method for oxidizing tertiary amines and aromatic heterocycles containing nitrogen
04/24/2003CA2461557A1 Novel prodrugs of n-h bond-containing compounds and methods of making thereof
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003EP1304121A1 Body weight gain inhibitors
04/23/2003EP1303514A1 Process for preparing azacycloalkanoylaminothiazoles
04/23/2003EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
04/23/2003EP1303511A1 Oxazolidinone derivatives as antimicrobials
04/23/2003EP1303509A1 Beta3 adrenergic agonists
04/23/2003EP1303502A2 Tetrahydrobenzothiazole analogues as neuroprotective agents
04/23/2003EP1303308A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003CN1106380C New synthetic catechol derivatives, method for production and use thereof
04/23/2003CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
04/22/2003US6552226 Tandem acyl-Claisen rearrangement in the preparation of chiral products
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552058 Oxazolidinedione derivatives and their use
04/22/2003US6552057 Serotonin 5-HT3 receptor partial activator
04/22/2003US6552042 Anticoagulants
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 210